Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Functional characterization of BcrR: a one-component transmembrane signal transduction system for bacitracin resistance.

Darnell RL, Nakatani Y, Knottenbelt MK, Gebhard S, Cook GM.

Microbiology. 2019 Apr;165(4):475-487. doi: 10.1099/mic.0.000781. Epub 2019 Feb 19.

PMID:
30777814
2.

A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.

Heimes AS, Schmidt M, Jäkel J, Almstedt K, Gebhard S, Weyer-Eiberich V, Elger T, Krajnak S, Brenner W, Hasenburg A, Battista MJ.

Arch Gynecol Obstet. 2019 Jan;299(1):239-246. doi: 10.1007/s00404-018-4941-z. Epub 2018 Oct 24.

PMID:
30357498
3.

Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.

Ishibashi K, Haber T, Breuksch I, Gebhard S, Sugino T, Kubo H, Hata J, Koguchi T, Yabe M, Kataoka M, Ogawa S, Hiraki H, Yanagida T, Haga N, Thüroff JW, Prawitt D, Brenner W, Kojima Y.

Oncotarget. 2017 Jul 21;8(33):55230-55245. doi: 10.18632/oncotarget.19420. eCollection 2017 Aug 15.

4.

[Towards bariatric surgery : taking your time preserves you from loosing your time].

Corminboeuf Y, Rieben I, Gebhard S, Pralong FP, Stiefel F.

Rev Med Suisse. 2017 Mar 22;13(555):650-654. French.

PMID:
28721707
5.

Troubles du comportement alimentaire et maternité : entre risque et opportunité.

Gebhard S.

Rev Med Suisse. 2017 Jan 25;13(547):207-208. French. No abstract available.

PMID:
28703977
6.

[Novelties 2016 in pediatrics].

Fischer Fumeaux CJ, Fletgen Richard C, Goncalves Pereira Pinto D, Stadelmann C, Avignon V, Vial Y, Tolsa JF, Ambresin AE, Armengaud JB, Castaneda M, Coti-Bertrand P, Deppen A, Duvoisin G, Gebhard S, Holzer L, Lier F, Monney Chaubert C, Pauchard JY, Typaldou SA, Hofer M.

Rev Med Suisse. 2017 Jan 11;13(544-545):92-95. Review. French.

PMID:
28703546
7.

Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.

Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Gebhard S, Foersch S, Rahnenführer J, Brenner W, Hasenburg A, Hengstler JG, Schmidt M.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1123-1131. doi: 10.1007/s00432-017-2377-7. Epub 2017 Mar 1.

PMID:
28251349
8.

Transporters as information processors in bacterial signalling pathways.

Piepenbreier H, Fritz G, Gebhard S.

Mol Microbiol. 2017 Apr;104(1):1-15. doi: 10.1111/mmi.13633. Epub 2017 Feb 24. Review.

9.

Insulation and wiring specificity of BceR-like response regulators and their target promoters in Bacillus subtilis.

Fang C, Nagy-Staroń A, Grafe M, Heermann R, Jung K, Gebhard S, Mascher T.

Mol Microbiol. 2017 Apr;104(1):16-31. doi: 10.1111/mmi.13597. Epub 2017 Jan 27.

10.

Application of a Bacillus subtilis Whole-Cell Biosensor (PliaI-lux) for the Identification of Cell Wall Active Antibacterial Compounds.

Kobras CM, Mascher T, Gebhard S.

Methods Mol Biol. 2017;1520:121-131. doi: 10.1007/978-1-4939-6634-9_7.

PMID:
27873249
11.

Substitution of the native srfA promoter by constitutive Pveg in two B. subtilis strains and evaluation of the effect on Surfactin production.

Willenbacher J, Mohr T, Henkel M, Gebhard S, Mascher T, Syldatk C, Hausmann R.

J Biotechnol. 2016 Apr 20;224:14-7. doi: 10.1016/j.jbiotec.2016.03.002. Epub 2016 Mar 4.

PMID:
26953743
12.

Anatomy of the bacitracin resistance network in Bacillus subtilis.

Radeck J, Gebhard S, Orchard PS, Kirchner M, Bauer S, Mascher T, Fritz G.

Mol Microbiol. 2016 May;100(4):607-20. doi: 10.1111/mmi.13336. Epub 2016 Mar 10.

13.

Cannibalism stress response in Bacillus subtilis.

Höfler C, Heckmann J, Fritsch A, Popp P, Gebhard S, Fritz G, Mascher T.

Microbiology. 2016 Jan;162(1):164-76. doi: 10.1099/mic.0.000176. Epub 2015 Sep 11.

PMID:
26364265
14.

A New Way of Sensing: Need-Based Activation of Antibiotic Resistance by a Flux-Sensing Mechanism.

Fritz G, Dintner S, Treichel NS, Radeck J, Gerland U, Mascher T, Gebhard S.

MBio. 2015 Jul 21;6(4):e00975. doi: 10.1128/mBio.00975-15.

15.

JNK-dependent gene regulatory circuitry governs mesenchymal fate.

Sahu SK, Garding A, Tiwari N, Thakurela S, Toedling J, Gebhard S, Ortega F, Schmarowski N, Berninger B, Nitsch R, Schmidt M, Tiwari VK.

EMBO J. 2015 Aug 13;34(16):2162-81. doi: 10.15252/embj.201490693. Epub 2015 Jul 8.

16.

Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

Sicking I, Rommens K, Battista MJ, Böhm D, Gebhard S, Lebrecht A, Cotarelo C, Hoffmann G, Hengstler JG, Schmidt M.

BMC Cancer. 2014 Dec 15;14:952. doi: 10.1186/1471-2407-14-952.

17.

A sensory complex consisting of an ATP-binding cassette transporter and a two-component regulatory system controls bacitracin resistance in Bacillus subtilis.

Dintner S, Heermann R, Fang C, Jung K, Gebhard S.

J Biol Chem. 2014 Oct 3;289(40):27899-910. doi: 10.1074/jbc.M114.596221. Epub 2014 Aug 12.

18.

Crystal structure of PhnF, a GntR-family transcriptional regulator of phosphate transport in Mycobacterium smegmatis.

Gebhard S, Busby JN, Fritz G, Moreland NJ, Cook GM, Lott JS, Baker EN, Money VA.

J Bacteriol. 2014 Oct;196(19):3472-81. doi: 10.1128/JB.01965-14. Epub 2014 Jul 21.

19.

Bacillus subtilis as a platform for molecular characterisation of regulatory mechanisms of Enterococcus faecalis resistance against cell wall antibiotics.

Fang C, Stiegeler E, Cook GM, Mascher T, Gebhard S.

PLoS One. 2014 Mar 27;9(3):e93169. doi: 10.1371/journal.pone.0093169. eCollection 2014.

20.

Defence against antimicrobial peptides: different strategies in Firmicutes.

Revilla-Guarinos A, Gebhard S, Mascher T, Zúñiga M.

Environ Microbiol. 2014 May;16(5):1225-37. doi: 10.1111/1462-2920.12400. Epub 2014 Feb 18. Review.

PMID:
24548478
21.

Identification and characterization of a bacitracin resistance network in Enterococcus faecalis.

Gebhard S, Fang C, Shaaly A, Leslie DJ, Weimar MR, Kalamorz F, Carne A, Cook GM.

Antimicrob Agents Chemother. 2014;58(3):1425-33. doi: 10.1128/AAC.02111-13. Epub 2013 Dec 16.

22.

The Bacillus BioBrick Box: generation and evaluation of essential genetic building blocks for standardized work with Bacillus subtilis.

Radeck J, Kraft K, Bartels J, Cikovic T, Dürr F, Emenegger J, Kelterborn S, Sauer C, Fritz G, Gebhard S, Mascher T.

J Biol Eng. 2013 Dec 2;7(1):29. doi: 10.1186/1754-1611-7-29.

23.

Identification of regions important for resistance and signalling within the antimicrobial peptide transporter BceAB of Bacillus subtilis.

Kallenberg F, Dintner S, Schmitz R, Gebhard S.

J Bacteriol. 2013 Jul;195(14):3287-97. doi: 10.1128/JB.00419-13. Epub 2013 May 17.

24.

Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation.

Golovchenko S, Hattori T, Hartmann C, Gebhardt M, Gebhard S, Hess A, Pausch F, Schlund B, von der Mark K.

Bone. 2013 Jul;55(1):102-12. doi: 10.1016/j.bone.2013.03.019. Epub 2013 Apr 6.

PMID:
23567158
25.

Undecaprenyl pyrophosphate phosphatase confers low-level resistance to bacitracin in Enterococcus faecalis.

Shaaly A, Kalamorz F, Gebhard S, Cook GM.

J Antimicrob Chemother. 2013 Jul;68(7):1583-93. doi: 10.1093/jac/dkt048. Epub 2013 Mar 3.

PMID:
23460607
26.

Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23.

Revilla-Guarinos A, Gebhard S, Alcántara C, Staron A, Mascher T, Zúñiga M.

Appl Environ Microbiol. 2013 May;79(10):3160-70. doi: 10.1128/AEM.00178-13. Epub 2013 Mar 1.

27.

[Liaison psychiatry nurse: the development of supervision in somatic medicine].

Dorogi Y, Campiotti C, Gebhard S.

Encephale. 2013 Jun;39(3):232-6. doi: 10.1016/j.encep.2012.10.007. Epub 2012 Dec 1. French.

PMID:
23206548
28.

Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.

Siggelkow W, Boehm D, Gebhard S, Battista M, Sicking I, Lebrecht A, Solbach C, Hellwig B, Rahnenführer J, Koelbl H, Gehrmann M, Marchan R, Cadenas C, Hengstler JG, Schmidt M.

BMC Cancer. 2012 Nov 27;12:562. doi: 10.1186/1471-2407-12-562.

29.

ABC transporters of antimicrobial peptides in Firmicutes bacteria - phylogeny, function and regulation.

Gebhard S.

Mol Microbiol. 2012 Dec;86(6):1295-317. doi: 10.1111/mmi.12078. Epub 2012 Nov 19. Review.

30.

Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.

Chen Z, Gerhold-Ay A, Gebhard S, Boehm D, Solbach C, Lebrecht A, Battista M, Sicking I, Cotarelo C, Cadenas C, Marchan R, Stewart JD, Gehrmann M, Koelbl H, Hengstler JG, Schmidt M.

PLoS One. 2012;7(9):e44741. doi: 10.1371/journal.pone.0044741. Epub 2012 Sep 28.

31.

A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.

Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, Boehm D, Gebhard S, Petry I, Lebrecht A, Cadenas C, Marchan R, Stewart JD, Solbach C, Holmberg L, Edlund K, Kultima HG, Rody A, Berglund A, Lambe M, Isaksson A, Botling J, Karn T, Müller V, Gerhold-Ay A, Cotarelo C, Sebastian M, Kronenwett R, Bojar H, Lehr HA, Sahin U, Koelbl H, Gehrmann M, Micke P, Rahnenführer J, Hengstler JG.

Clin Cancer Res. 2012 May 1;18(9):2695-703. doi: 10.1158/1078-0432.CCR-11-2210. Epub 2012 Feb 20.

32.

p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer.

Seeger A, Kölbl H, Petry IB, Gebhard S, Battista MJ, Böhm D, Steiner E.

Gynecol Oncol. 2012 Apr;125(1):200-7. doi: 10.1016/j.ygyno.2011.12.443. Epub 2011 Dec 28.

PMID:
22210468
33.

Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome.

Gebhard S, Steil L, Peters B, Gesell-Salazar M, Hammer E, Kuttler B, Clemetson KJ, Scharf C, Peters J, Völker U, Rettig R, Greinacher A.

J Hypertens. 2011 Nov;29(11):2126-37. doi: 10.1097/HJH.0b013e32834b1991.

PMID:
21946693
34.

Antimicrobial peptide sensing and detoxification modules: unravelling the regulatory circuitry of Staphylococcus aureus.

Gebhard S, Mascher T.

Mol Microbiol. 2011 Aug;81(3):581-7. doi: 10.1111/j.1365-2958.2011.07747.x. Epub 2011 Jul 12.

35.

Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes Bacteria.

Dintner S, Staron A, Berchtold E, Petri T, Mascher T, Gebhard S.

J Bacteriol. 2011 Aug;193(15):3851-62. doi: 10.1128/JB.05175-11. Epub 2011 Jun 10.

36.

[Anorexia: somatic assessment and management].

Giusti V, Gebhard S.

Rev Med Suisse. 2011 Mar 30;7(288):711-5. French.

PMID:
21545021
37.

[Anorexia and bulimia: the canton of Vaud's experience of an interdisciplinary approach].

Gebhard S, Dorogi Y, Giusti V, Stagno D, Lanz M, Schmidt D, Chaubert CM, Laget J, Michaud PA, Stiefel F.

Rev Med Suisse. 2011 Feb 16;7(282):381-4. French.

PMID:
21416864
38.

Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.

Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG.

Breast Cancer Res Treat. 2011 Feb;125(3):637-46. doi: 10.1007/s10549-010-0856-5. Epub 2010 Mar 30.

PMID:
20352488
39.

The SigF regulon in Mycobacterium smegmatis reveals roles in adaptation to stationary phase, heat, and oxidative stress.

Hümpel A, Gebhard S, Cook GM, Berney M.

J Bacteriol. 2010 May;192(10):2491-502. doi: 10.1128/JB.00035-10. Epub 2010 Mar 16.

40.

SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.

Hattori T, Müller C, Gebhard S, Bauer E, Pausch F, Schlund B, Bösl MR, Hess A, Surmann-Schmitt C, von der Mark H, de Crombrugghe B, von der Mark K.

Development. 2010 Mar;137(6):901-11. doi: 10.1242/dev.045203.

41.

ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.

Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenführer J, Maccoux L, West J, Kölbl H, Schuler M, Hengstler JG.

Clin Cancer Res. 2010 Jan 15;16(2):451-60. doi: 10.1158/1078-0432.CCR-09-1617. Epub 2010 Jan 12.

42.

The low-affinity phosphate transporter PitA is dispensable for in vitro growth of Mycobacterium smegmatis.

Gebhard S, Ekanayaka N, Cook GM.

BMC Microbiol. 2009 Dec 10;9:254. doi: 10.1186/1471-2180-9-254.

43.

Direct stimulus perception and transcription activation by a membrane-bound DNA binding protein.

Gebhard S, Gaballa A, Helmann JD, Cook GM.

Mol Microbiol. 2009 Aug;73(3):482-91. doi: 10.1111/j.1365-2958.2009.06787.x. Epub 2009 Jul 7.

44.

Physiology of mycobacteria.

Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, Danilchanka O, Niederweis M.

Adv Microb Physiol. 2009;55:81-182, 318-9. doi: 10.1016/S0065-2911(09)05502-7. Review.

45.

Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.

Skala CE, Petry IB, Gebhard S, Hengstler JG, Albrich SB, Maltaris T, Naumann G, Koelbl H.

Regen Med. 2009 Mar;4(2):197-204. doi: 10.2217/17460751.4.2.197.

PMID:
19317640
46.

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.

Clin Cancer Res. 2008 Sep 15;14(18):5849-55. doi: 10.1158/1078-0432.CCR-08-0669.

47.

The alternative sigma factor SigF of Mycobacterium smegmatis is required for survival of heat shock, acidic pH and oxidative stress.

Gebhard S, Hümpel A, McLellan AD, Cook GM.

Microbiology. 2008 Sep;154(Pt 9):2786-95. doi: 10.1099/mic.0.2008/018044-0.

PMID:
18757812
48.

Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.

Gebhard S, Hattori T, Bauer E, Schlund B, Bösl MR, de Crombrugghe B, von der Mark K.

Matrix Biol. 2008 Oct;27(8):693-9. doi: 10.1016/j.matbio.2008.07.001. Epub 2008 Jul 12.

49.

Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model.

Hermes M, Schormann W, Brulport M, Uhlemann K, Lupatsch F, Horn LC, Schumann A, Allgaier C, Weishaupt M, Engeland K, Müller GA, Mössner J, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Lausch E, Prawitt D, Wilhelm C, Hengstler JG.

Br J Cancer. 2008 May 6;98(9):1525-32. doi: 10.1038/sj.bjc.6604318. Epub 2008 Apr 29.

50.

Molecular analysis of BcrR, a membrane-bound bacitracin sensor and DNA-binding protein from Enterococcus faecalis.

Gauntlett JC, Gebhard S, Keis S, Manson JM, Pos KM, Cook GM.

J Biol Chem. 2008 Mar 28;283(13):8591-600. doi: 10.1074/jbc.M709503200. Epub 2008 Jan 28.

Supplemental Content

Loading ...
Support Center